patients were entered as matched pairs serially according to time of admission , trial centre , cytostatic therapy ( cyclophosphamide , endoxan ; ifosfamide , holoxan ) and tumor diagnosis , and were given uroprotection at random either with mesna or standard prophylactic measures .
C0010583
cyclophosphamide
C0020823
ifosfamide